News Center

A modern veterinary drug GMP pharmaceutical enterprise relying on high technology, integrating scientific research, development, production, sales and service

On December 25, Qingdao Zhongren Animal Medicine Co., Ltd. passed GMP re-inspection

Release time:

2020-12-26


Congratulations! Qingdao Zhongren Animal Medicine Co., Ltd. passed GMP re-inspection

Source: Qingdao Zhongren Animal Medicine Co., Ltd.

图片

图片

 

On December 24-25, 2020, the GMP acceptance expert group appointed by the Shandong Provincial Animal Husbandry and Veterinary Bureau, accompanied by the city bureau personnel, came to Zhongren to conduct a GMP on-site re-inspection of Qingdao Zhongren Animal Drugs Co. (GMP re-inspection passed the acceptance on the 25th)

After the general manager of Qingdao Zhongren Animal Drug Co., Ltd. made an on-site report on the company's GMP operation, the expert group inspected and accepted the hardware facilities such as chemical drug production workshop, quality inspection, warehouse, finished product warehouse, veterinary drug production, quality, material management, staffing, health management, operation records, etc.

 

 

During the acceptance process, the experts of the provincial bureau guided the implementation of the company's GMP management and put forward valuable suggestions through the first meeting, on-site facilities and equipment inspection, on-site test operation assessment, and inspection documents.

 

 

After discussion by the inspection expert group, the comprehensive evaluation finally passed the GMP retest of Zhongren's drug with a high score.

This acceptance has also received strong support from relevant departments. With German Pharmaceutical Puai Life, Qingdao Zhongren Animal Drug Co., Ltd. will make persistent efforts to escort the healthy development of the animal protection industry.